1Karrillon GJ,Morice MC, Benveniste E,et al. Intracoronary stent implantation with replacement of conventional anticoagulation by antiplatelet therapy. 30 - day clinical outcome of the French Multicenter Registry. Circulation, 1996,94 (7) : 1519 - 1527.
2Moussa I,Di Mario C, Reimers B, et al. Subacute stent thrombosis in the era of intravascular ultrasound - guided coronary stenting without anticoagulation :frequency,predictors and clinical outcome. J Am Coll Cardiol, 1997,29( 1 ) :6 - 12.
3Orford JL, Lennon R, Melby S, et al. Frequency and correlates of coronary stent thrombosis in the modem era:analysis of a single center registry. J Am Coil Cardiol,2002,40(9) :1567 -1572.
5Ong AT,Hoye A,Aoki J,et al. Thirty - day incidence and six - month clinical outcome of thrombotic stent occlusion after bare - metal, sirolimus,or paditaxd stent implantation. J Am Coll Cardiol, 2005,45(6) :947 -953.
6Mehran R, Aymong ED, Ashby DT, et al. Safety of an aspirin - alone regimen after intracorenary stenting with a heparin -coated stent:final results of the HOPE( HEPACOAT and an Antithrembotic Regimen of Aspirin Alone) study. Circulation,2003,108 (9) : 1078 - 1083.
7陈修.心血管药理学（第2版）[M].北京:人民卫生出版社,1998.218.
8Patrono C ,Ciabattoni G,Pinca E,et al. Low dose aspirin and inhibition of thromhoxane B2 production in healthy subjects. Thromb Res,1980,17(3) :317 -327.
9Bahit MC, Granger CB, Wallentin Li, et al. Persistence of the prothrombotic state after acute coronary syndromes: implications for treatment. Am Heart J,2002,143(2) :205 -216.
10Shafts PJ, Cannon CP, Loscalzo J. The antiplatelet effects of ficlopidine and clopidogrel. Ann Intern Med, 1998,129 ( 5 ) :394 - 405.
二级参考文献8
1Steinhubl SR, Berger PB, Mann JT 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA, 2002, 288: 2411-2420.
2Chart AW, Molitemo DJ, Berger PB, et al. Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tiroffixan and ReoProGive Similar Ettlcacy Outcome Trial (TARGET). J Am CollCardiol, 2003,42:1188-1195.
3Muller I, Seyfarth M, Rudiger S, et al. Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart, 2001,85:92-93.
4Rao AK, Pratt C, Berke A, et al. Thrombolysis in Myocardial Infarction (TIMI) TriM-phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patient streated with recombinant tissue plasminogen activator and streptokinase.J Am Coil Cardiol, 1988,11:1-11.
5Biondi-Zoeeai GG, Agostoni P, Testa L, et al. Increased mortality after coronary stenting in patients treated with clopidogrel without loading dose. Evidence from a meta-analysis. Minerva Cardioangiol,2004,52:195-208.
6Kastrati A, Mehilli J, Schuhlen H, et al. A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med, 2004,350:232-238.
7Pache J, Kastrati A, Mehilli J, et al. Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen.Catheter Cardiovasc Interv, 2002,55:436--441.
8Gawaz M, Seyfarth M, Muller I, et al. Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. Am J Cardiol. 2001. 87 : 332-336.
9Sabatine MS,Cannon CP,Gibson CM,et al.Effect of clop idngrel p re2treatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolyties:the PCI-CLAR ITY study.JAM.A,2005,294 (10):1224-1232.
10Popma JJ,Berger P,Ohman EM,et al.Antithrornbetic therapy during percutancous coronary intervention:the Seventh ACCP Conference on Antithrombotic and herapy.Chest,2004,126 (3):5761S-5799S.
